Triglycerides
Icosapent Ethyl for CV Risk Reduction
This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.
August 11, 2025
This fifth graphic delineates how icosapent ethyl can be used for CV risk reduction as demonstrated by the REDUCE-IT trial.
The series was sponsored by an unrestricted educational grant from Amarin.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
